Abstract:Osteoclast lineage commitment and differentiation have been studied extensively, although the mechanism by which transcription factor(s) control osteoclast terminal differentiation, activation, and function remains unclear. CCAAT/enhancer-binding protein alpha (C/ebp alpha) has been reported to be a key regulator of osteoclast cell lineage commitment, yet C/ebp alpha's roles in osteoclast terminal differentiation, activation and function, and bone homeostasis, under physiological or pathological conditions, have not been studied because newborn C/ebp alpha-null mice die within several hours after birth. Furthermore, the function of C/ebp alpha in osteoclast terminal differentiation, activation, and function is largely unknown. Herein, we generated and analyzed an osteoclast-specific C/ebp alpha conditional knockout (CKO) mouse model via Ctsk-Cre mice and found that C/ebp alpha-deficient mice exhibited a severe osteopetrosis phenotype due to impaired osteoclast terminal differentiation, activation, and function, including mildly reduced osteoclast number, impaired osteoclast polarization, actin formation, and bone resorption, which demonstrated the novel function of C/ebp alpha in cell function and terminal differentiation. Interestingly, C/ebp alpha deficiency did not affect bone formation or monocyte/macrophage development. Our results further demonstrated that C/ebp alpha deficiency suppressed the expression of osteoclast functional genes, e.g. encoding cathepsin K (Ctsk), Atp6i (Tcirg1), and osteoclast regulator genes, e.g. encoding c-fos (Fos), and nuclear factor of activated T-cells 1 (Nfatc1), while having no effect on Pu.1 (Spi1) expression. Promoter activity mapping and ChIP assay defined the critical cis-regulatory element (CCRE) in the promoter region of Nfatc1, and also showed that the CCREs were directly associated with C/ebp alpha, which enhanced the promoter's activity. The deficiency of C/ebp alpha in osteoclasts completely blocked ovariectomy-induced bone loss, indicating that C/ebp alpha is a promising new target for the treatment of osteolytic diseases. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Cbfβ deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfβ required for skeletal development

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

The Deubiquitinase UCHL1 Negatively Controls Osteoclastogenesis by Regulating TAZ/NFATC1 Signalling

mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression

Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

Essential Role of Β-Catenin in Postnatal Bone Acquisition

Postnatal Deletion of -catenin in Preosteoblasts Regulates Global Energy Metabolism through Increasing Bone Resorption and Adipose Tissue Fibrosis

RUNX2 Regulates Osteoblast Differentiation via the BMP4 Signaling Pathway

RNF40 exerts stage-dependent functions in differentiating osteoblasts and is essential for bone cell crosstalk

C/Ebp Alpha Controls Osteoclast Terminal Differentiation, Activation, Function, And Postnatal Bone Homeostasis Through Direct Regulation Of Nfatc1

Cdh1 Regulates Craniofacial Development Via Apc-Dependent Ubiquitination and Activation of Goosecoid

The Microtubule-Associated Protein DCAMKL 1 Regulates Osteoblast Function Via Repression of Runx 2

Pin1-mediated Runx2 modification is critical for skeletal development

New Function of RUNX2 in Regulating Osteoclast Differentiation via the AKT/NFATc1/CTSK Axis

Identification a novel de novo RUNX2 frameshift mutation associated with cleidocranial dysplasia

The RNF146 E3 Ubiquitin Ligase is Required for the Control of Wnt Signaling and Body Pattern Formation in Xenopus

Functional analysis of novel RUNX2 mutations in cleidocranial dysplasia.

Delayed tooth movement in Runx2+/- mice associated with mTORC2 in stretch-induced bone formation